Company news

Hims & Hers Health, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date

October 21, 2026

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

October 12, 2026

Hers Launches in Australia, Built to Care for the Whole Woman

October 12, 2026

Hims & Hers Names Jon Franklin as Chief Accounting Officer

October 7, 2026

Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market

August 31, 2026

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

August 12, 2026

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

August 10, 2026

Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience

August 6, 2026

Hims & Hers Responds to FTC Lawsuit

July 29, 2026

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

July 17, 2026

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

July 13, 2026

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

June 4, 2026

Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

June 3, 2026

Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

June 2, 2026

Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

June 2, 2026

Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

May 28, 2026

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

May 21, 2026

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

May 18, 2026

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

May 18, 2026

Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results

May 11, 2026

Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors

April 28, 2026

Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

April 13, 2026

Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers

March 26, 2026

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

March 10, 2026

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

March 10, 2026

Hims & Hers Announces Strategic Shift for US Weight Loss Business

March 9, 2026

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

February 23, 2026

Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

February 19, 2026

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

February 5, 2026

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

February 5, 2026

Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

February 4, 2026

Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

February 2, 2026

Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over

January 29, 2026

Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees

January 28, 2026

Hims & Hers Brings Comprehensive Weight Loss Programme to the UK

December 10, 2025

Hims & Hers Now Serving Customers in Canada

December 4, 2025

Hims & Hers Continues Major International Expansion With Official Entry Into Canada

December 4, 2025

Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology

December 3, 2025

Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization

November 17, 2025

Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy

November 17, 2025

Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys

November 13, 2025

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

November 3, 2025

Liberate Earns Spot on Redpoint's Prestigious AI64 List of Top Emerging Enterprise AI Companies

October 27, 2025

Maxima Named to Redpoint’s AI64: Celebrating the Top Emerging Enterprise AI Applications

October 23, 2025

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026

October 15, 2025

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025

October 13, 2025

Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office

October 9, 2025

Roundhill Launches Meme Stock ETF (MEME)

October 8, 2025

Leverage Shares Launches First 3x Single-Stock ETPs on HOOD, HIMS, UNH and Others

September 16, 2025

Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

September 10, 2025

Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.